Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
127337-60-4Cc1c(OCC(F)(F)F)ccnc1CCl.ClCMZBQUWICURDCD-UHFFFAOYSA-N127337-60-4DTXSID40584470Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H317 (94.2%): May cause an allergic skin reaction [Warning Sensitization, Skin];H318 (95.2%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
P261, P264+P265, P272, P280, P302+P352, P305+P354+P338, P317, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 104 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Verwenden2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine Hydrochloride is an intermediate for Lansoprazole (L175000), which is used as a gastric proton pump inhibitor.
Wird geladen…
Wird geladen…
Wird geladen…